LIBERTY LATIN AMERIC-CL C (LILAK)

BMG9001E1286 - Common Stock

7.94  +0.21 (+2.72%)

After market: 7.73 -0.21 (-2.64%)

Fundamental Rating

3

Taking everything into account, LILAK scores 3 out of 10 in our fundamental rating. LILAK was compared to 35 industry peers in the Diversified Telecommunication Services industry. While LILAK is still in line with the averages on profitability rating, there are concerns on its financial health. LILAK does not seem to be growing, but still is valued expensively.



4

1. Profitability

1.1 Basic Checks

In the past year LILAK has reported negative net income.
LILAK had a positive operating cash flow in the past year.
LILAK had negative earnings in each of the past 5 years.
Each year in the past 5 years LILAK had a positive operating cash flow.

1.2 Ratios

LILAK has a Return On Assets (-0.54%) which is in line with its industry peers.
LILAK has a Return On Equity (-4.17%) which is comparable to the rest of the industry.
LILAK's Return On Invested Capital of 4.17% is fine compared to the rest of the industry. LILAK outperforms 62.86% of its industry peers.
LILAK had an Average Return On Invested Capital over the past 3 years of 4.37%. This is in line with the industry average of 5.67%.
Industry RankSector Rank
ROA -0.54%
ROE -4.17%
ROIC 4.17%
ROA(3y)-1.56%
ROA(5y)-1.99%
ROE(3y)-11.02%
ROE(5y)-12.56%
ROIC(3y)4.37%
ROIC(5y)3.87%

1.3 Margins

LILAK's Operating Margin of 13.40% is fine compared to the rest of the industry. LILAK outperforms 68.57% of its industry peers.
LILAK's Operating Margin has declined in the last couple of years.
The Gross Margin of LILAK (77.38%) is better than 97.14% of its industry peers.
LILAK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.4%
PM (TTM) N/A
GM 77.38%
OM growth 3Y3.14%
OM growth 5Y-2.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.36%

2

2. Health

2.1 Basic Checks

LILAK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, LILAK has less shares outstanding
LILAK has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LILAK has a worse debt to assets ratio.

2.2 Solvency

LILAK has an Altman-Z score of 0.28. This is a bad value and indicates that LILAK is not financially healthy and even has some risk of bankruptcy.
LILAK's Altman-Z score of 0.28 is on the low side compared to the rest of the industry. LILAK is outperformed by 71.43% of its industry peers.
The Debt to FCF ratio of LILAK is 26.22, which is on the high side as it means it would take LILAK, 26.22 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LILAK (26.22) is comparable to the rest of the industry.
LILAK has a Debt/Equity ratio of 4.31. This is a high value indicating a heavy dependency on external financing.
LILAK has a worse Debt to Equity ratio (4.31) than 82.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF 26.22
Altman-Z 0.28
ROIC/WACC0.6
WACC7%

2.3 Liquidity

A Current Ratio of 1.13 indicates that LILAK should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.13, LILAK is in line with its industry, outperforming 57.14% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that LILAK should not have too much problems paying its short term obligations.
LILAK's Quick ratio of 1.13 is in line compared to the rest of the industry. LILAK outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 67.53% over the past year.
LILAK shows a decrease in Revenue. In the last year, the revenue decreased by -6.29%.
Measured over the past years, LILAK shows a small growth in Revenue. The Revenue has been growing by 4.01% on average per year.
EPS 1Y (TTM)67.53%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-181.36%
Revenue 1Y (TTM)-6.29%
Revenue growth 3Y6.05%
Revenue growth 5Y4.01%
Revenue growth Q2Q0.25%

3.2 Future

Based on estimates for the next years, LILAK will show a very strong growth in Earnings Per Share. The EPS will grow by 74.85% on average per year.
The Revenue is expected to grow by 2.93% on average over the next years.
EPS Next Y44.92%
EPS Next 2Y129.14%
EPS Next 3Y74.85%
EPS Next 5YN/A
Revenue Next Year1.58%
Revenue Next 2Y2.78%
Revenue Next 3Y2.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LILAK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LILAK indicates a somewhat cheap valuation: LILAK is cheaper than 77.14% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LILAK is valued cheaper than 94.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.22
EV/EBITDA 5.44

4.3 Compensation for Growth

LILAK's earnings are expected to grow with 74.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y129.14%
EPS Next 3Y74.85%

0

5. Dividend

5.1 Amount

LILAK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (5/2/2024, 7:04:39 PM)

After market: 7.73 -0.21 (-2.64%)

7.94

+0.21 (+2.72%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.63B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -4.17%
ROCE
ROIC
ROICexc
ROICexgc
OM 13.4%
PM (TTM) N/A
GM 77.38%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)67.53%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y44.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.29%
Revenue growth 3Y6.05%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y